News Focus
News Focus
Followers 280
Posts 31200
Boards Moderated 0
Alias Born 07/06/2012

Re: namtae post# 195220

Wednesday, 04/20/2016 8:54:16 AM

Wednesday, April 20, 2016 8:54:16 AM

Post# of 446893
WHAT promos??? Post the promos. Let me guess - they won't be posted.

Share overhang??? Post that as well.

This is what is coming and nobody is going to stop it.

Elite Announces U.S. FDA Priority Review Designation For SequestOx™ NDA
SequestOx™ NDA Submission Accepted for Review


NORTHVALE, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced that the New Drug Application (NDA) for SequestOXTM (ELI-200), Elite's lead opioid abuse-deterrent candidate for the management of moderate to severe pain where the use of an opioid analgesic is appropriate, has been accepted and granted priority review by the United States Food and Drug Administration ("FDA"). The FDA has set a target action date under the Prescription Drug User Fee Act ("PDUFA") of July 14, 2016.

Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News